Drug Delivery Business

Chiltern acquires Integrated Development Associates

By

Chiltern Integrated Development AssociatesContract research organization Chiltern announced today that it is expanding its Japanese and Asian presence through its purchase of Integrated Development Associates.

Financial terms of the deal were not disclosed.

IDA has staff in Japan, Korea and Southeast Asia – and offers opportunities to integrate the region into global drug development, according to Chiltern. IDA’s expertise includes establishing regulatory and development pathways in Japan, and implementing clinical trials across Asia.

Get the full story on our sister site, Medical Design & Outsourcing.

IN CASE YOU MISSED IT

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.